What did @____britaylor actually say?
She finished week two of semaglutide (she calls it "oseptic," likely Ozempic or a compounded version) and reported losing four pounds in week one and two pounds in week two, totaling six pounds. Her main reported benefit was "no hunger," reduced bloating, and keeping the weight off rather than cycling through water-weight fluctuations. She also mentioned taking her shot after work to avoid day-one nausea.
She was upfront that she is already a "smaller sized girl" and that her goal is shedding post-pregnancy weight, not dramatic transformation. She offered to tell followers where she sourced it and what she paid, which raises its own questions we'll get to.
Does the science back this up?
The weight loss numbers she described are plausible but sit at the high end of what the evidence predicts this early, and the mechanism she credits, appetite suppression, is well-documented. What the studies actually show is more complicated.
Semaglutide activates GLP-1 receptors in the hypothalamus, slowing gastric emptying and reducing hunger signaling. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed average weight loss of roughly 15% of body weight over 68 weeks at the full 2.4 mg dose. In the first two weeks at starter doses (0.25 mg), losses are typically modest, often one to three pounds, driven partly by reduced caloric intake and partly by water weight as glycogen stores shift. Six pounds in two weeks is on the higher end for a starter dose, but not impossible, especially if caloric intake dropped sharply.
Her observation that she is "keeping the weight off" unlike before is consistent with the drug's mechanism. GLP-1 agonists reduce appetite hormonally, not just through willpower, which is why losses tend to be more durable early on compared with diet-only approaches.
What did they get wrong (or right)?
She gets credit for a few things. Timing the injection for evenings to blunt nausea during waking hours is a practical strategy some clinicians actually suggest, and her framing of early side effects as manageable is accurate for most people at low doses. She also did not claim the drug will fix everything or promise specific outcomes to viewers.
What she got wrong, or at least incomplete, is presenting six pounds of loss as straightforwardly meaningful at two weeks. Early rapid loss on semaglutide frequently includes a water-weight component. Davies et al. (2021, Lancet) noted that short-term losses in the first weeks often reflect glycogen depletion and fluid shifts, not just fat. That does not mean it is fake progress, but calling it "keeping the weight off" after two weeks oversells how much is confirmed fat loss at this stage.
The bigger issue: she offered to share her source and price. If this is compounded semaglutide from an unregulated or gray-market source, that carries real risks. Compounded GLP-1 products are not FDA-approved, dosing accuracy varies, and the FDA has issued warnings about compounded semaglutide products specifically (FDA Drug Safety Communication, 2024).
What should you actually know?
Early results on semaglutide are often encouraging, but two weeks is not enough time to separate fat loss from fluid shifts or to know how your body will respond at higher doses. The appetite suppression she describes, "I'm never freaking hungry," is real and well-supported by clinical data, but it can also cause people to under-eat protein and micronutrients without realizing it, which matters especially for someone smaller-framed.
For post-pregnancy weight specifically, semaglutide is not studied extensively in the postpartum population, and if someone is breastfeeding, it is contraindicated. She did not mention this, and neither will most TikTok influencers.
The sourcing question matters more than her tone suggests. The STEP trials used pharmaceutical-grade semaglutide at verified doses. Compounded versions, while sometimes legitimate when prepared by an FDA-registered 503B outsourcing facility, vary widely in quality. Encouraging followers to ask "where I got it from" without that context is the part of this video that deserves the most skepticism.
- Semaglutide is clinically effective for weight loss, with strong trial data behind it.
- Two-week results are real but not fully interpretable yet.
- Sourcing and dose accuracy matter enormously with GLP-1 medications.
- Post-pregnancy use has limited specific clinical guidance.